Zomedica Corp.

AMEX: ZOM · Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM

Zomedica Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net Income
-62.19M -55.99M -37.3M -34.53M -14.93M -19.44M -19.46M -17.02M -17.5M -18.85M -18.28M -18.38M -19.27M -17.9M -18.5M -16.91M -15.6M -13.46M -10.56M
Depreciation & Amortization
7.81M 7.37M 6.87M 6.3M 5.66M 5.22M 4.59M 4.04M 3.64M 2.59M 1.85M 1.14M 431.04K 447.46K 469.77K 530.02K 614.04K 688.16K 761.85K
Stock-Based Compensation
3.54M 4.73M 5.6M 6.26M 6.6M 6.85M 7.62M 7.89M 9.04M 8.56M 7.85M 7.09M 5.68M 4.43M 2.78M 1.66M -2.06M -2.05M -2.92M
Other Working Capital
3.38M -1.09M 800.47K 976.47K -3.32M -2.96M -5.1M -4.87M -5.18M -3.9M -2.92M -2.47M 3.68K -604.69K -1M -877.09K -787.53K 227.62K 277.71K
Other Non-Cash Items
34.59M 34.66M 13.84M 8.7M -967K 802K 1.48M 2.41M 546.69K 947.34K 287.34K 32.52K 41.86K 47.22K 42.24K 22.07K -16.28M -17.64M -17.65M
Deferred Income Tax
-1.74M -2.16M -2.56M -2.38M -3.44M -2.95M -3.02M -3.3M -3.45M -3.45M -3.29M -2.8M -229.14K -233.94K 270.19K 180.13K 18.96M 18.96M 18.96M
Change in Working Capital
4.38M -477.39K -520.55K -140.55K -6.27M -3.57M -4.65M -5.7M -8.98M -8.73M -5.04M -3.88M 1.29M 488.24K -1.77M -1.72M -1.06M -1.52M -7.08M
Operating Cash Flow
-23.83M -22.06M -19.12M -15.78M -13.34M -13.09M -13.46M -11.67M -14.19M -16.42M -14.11M -14.28M -12.06M -12.72M -16.7M -16.24M -15.42M -13.67M -16.39M
Capital Expenditures
4.19M -1.25M -1.94M -4.55M -13.72M -7.77M -5.91M -1.03M -909.65K -535.82K -591.07K -526.17K -358.7K -158.15K -34.9K -16.79K -30.55K -612.37K -617.85K
Cash Acquisitions
-11.03M -23.74M -40.98M -40.98M -54.26M -65.85M -48.61M -48.61M -95.31M -71.01M -71.01M -71.01M 224.00 76.16 75.00 n/a n/a n/a n/a
Purchase of Investments
-10.84M 9.42M 17.93M 120.24K -4.09M -131.3M -140.37M -130.55M -115.5M -1M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
9.01M 38.44M 50.3M 34.24M -102.56M -94.32M -111.55M -103.48M 24.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
21.14M -15.38M 2.28M 12.71M 164.68M 153.53M 135.98M 127.79M -95.7M -71.89M -71.62M -71.5M -80.78K -81.54K 14.46K 1.02M 976.97K 476.09K 470.62K
Investing Cash Flow
12.01M 2.34M 21.96M 1.54M -9.95M -145.71M -170.47M -155.88M -212.11M -73.43M -72.11M -71.93M -343.48K -143.07K -19.82K 1.01M 976.97K 395.14K 389.67K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -14.27M -14.27M -14.27M -14.27M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-70K n/a n/a n/a n/a 8K 8K 8K 31K 423K -12.38M 19.63M 32.25M 60.45M 106.57M 74.21M 61.49M 32.9M -463.73K
Financial Cash Flow
-223.65K 7.19M 7.19M 7.19M 7.34M 7.81K 7.81K 7.81K 31K 423K 1.89M 219.16M 231.78M 259.97M 291.83M 76.71M 63.99M 35.4M 14.04M
Net Cash Flow
-12.04M -20.01M 2.59M -14.45M -23.31M -158.81M -183.98M -167.55M -226.32M -89.45M -84.26M 132.96M 219.38M 247.11M 275.11M 61.48M 49.54M 22.12M -1.96M
Free Cash Flow
-19.64M -23.31M -21.06M -20.33M -27.07M -20.86M -19.37M -12.7M -15.1M -16.95M -14.7M -14.8M -12.42M -12.88M -16.74M -16.26M -15.45M -14.28M -17M